文献速递系统性红斑狼疮

多组学分析揭示与狼疮预后相关的免疫细胞致敏特征

Multi-Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis.
PubMed 文献 · Arthritis Rheumatol · 2026-04-20

该研究整合87例系统性红斑狼疮(SLE)患者的免疫细胞、蛋白质和转录组数据与疾病活动及损伤指数,识别出三种独立蛋白质特征对应不同器官病理和免疫扰动。其中一种免疫细胞致敏蛋白特征富集于肾脏受累患者,提示六年器官损伤累积风险升高,且仅见于血清蛋白质组数据,联合特征总患病率为94%。

要点

  • 整合多组学数据在87例SLE患者中识别出三种独立蛋白质特征。
  • 免疫细胞致敏蛋白特征与肾脏受累及六年器官损伤累积风险升高相关。
  • 该特征仅见于血清蛋白质组数据且优于常规评估,联合特征患病率94%。

核心结论

  • SLE存在平行的免疫机制,多维整合分析可揭示与器官病理和预后相关的蛋白质特征。

研究设计与样本

  • 整合87例SLE患者的免疫细胞、蛋白质和转录组数据与疾病活动及损伤指数进行多维分析。

主要发现

  • 识别出三种独立蛋白质特征,分别对应不同器官病理和免疫扰动,包括I型干扰素和粒细胞通路。
  • 发现一种先前未表征的免疫细胞致敏蛋白特征,富集于肾脏受累患者并提示六年器官损伤累积风险升高。
  • 该致敏特征仅见于血清蛋白质组数据,且优于常规评估。
  • 三种蛋白质特征联合患病率为94%。

临床怎么用

  • 血清蛋白质组中的免疫细胞致敏特征或可用于识别肾脏受累及高器官损伤风险的SLE患者。
  • 多维蛋白质特征框架有助于发现新的治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic lupus erythematosus (SLE) is a multiorgan disease with widespread immune dysregulation and significant unmet clinical need. Blood-based gene expression studies have advanced our understanding of SLE pathogenesis but may overlook critical tissue-specific mechanisms that drive disease heterogeneity and progression. We posited that integrated multidimensional profiling could reveal novel molecular patterns underlying distinct SLE pathologies. METHODS: Here, we integrated immune cell, protein, and transcriptome data sets with disease activity and damage indices across 87 patients with SLE to reveal three independent protein signatures corresponding to discrete organ pathologies and immune perturbations. RESULTS: Alongside type I interferon and granulocyte pathways, our multidimensional analyses identified a previously uncharacterized immune cell priming protein signature that was enriched in patients with renal involvement and was indicative of elevated risk of six-year organ damage accrual. This minimally invasive signature outperformed conventional assessments and was only found in the serum proteomics data. Collectively, the protein signatures demonstrated a combined prevalence of 94%, reflecting their broad relevance to SLE. CONCLUSION: Together, these results reveal parallel immune mechanisms in SLE and provide a framework to identify new therapeutic targets. Clinical and immune data are available for public exploration through the interactive SLE Immune Atlas.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Smith MA, Sinibaldi D, Rahman S, et al. Multi-Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis. Arthritis Rheumatol. 2026. PMID: 41733120. doi:10.1002/art.70105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。